Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Mathé

Showing results (71-80 of 550) with videos related to

Pageof 55
Sort By:
La Nouvelle Presse Medicale|February 28, 1976
[Clinical pharmacology: the Swedish model]G Mathé
La Revue Du Praticien|April 1, 1976
[Non-Hodgkinian hematosarcomas (lymphosarcomas and reticulosarcomas). Introduction, classification and pretherapeutic topographic survey]G Mathé
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1994
Cancer and obesity, nutrition and hormones?G Mathé
ZWR|April 10, 1971
[Plastics in the manufacture of anterior bridges]G Mathé
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1984
[Delta agent]G Mathé
The New England Journal of Medicine|February 2, 1978
Survival of patients with polycythemia vera on busulfan or 32PG Mathé
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 22, 2002
Thalidomide, a drug which may protect the organism against some aggressive effects of the immunologic systemG Mathé
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 2, 1998
Lymphocytes: attackers and targets of the same oncogenic viruses, depending on their immunogenic strengthG Mathé
ZWR|January 10, 1973
[New ways in crown and bridge constructions]G Mathé
Drugs|January 1, 1974
Current status of immunotherapy of human cancers: leukaemias, lymphomas, solid tumoursG Mathé
Pageof 55

Showing results (71-80 of 550) with videos related to

Sort By:
Pageof 55
La Nouvelle Presse Medicale|February 28, 1976
[Clinical pharmacology: the Swedish model]G Mathé
La Revue Du Praticien|April 1, 1976
[Non-Hodgkinian hematosarcomas (lymphosarcomas and reticulosarcomas). Introduction, classification and pretherapeutic topographic survey]G Mathé
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1994
Cancer and obesity, nutrition and hormones?G Mathé
ZWR|April 10, 1971
[Plastics in the manufacture of anterior bridges]G Mathé
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1984
[Delta agent]G Mathé
The New England Journal of Medicine|February 2, 1978
Survival of patients with polycythemia vera on busulfan or 32PG Mathé
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 22, 2002
Thalidomide, a drug which may protect the organism against some aggressive effects of the immunologic systemG Mathé
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 2, 1998
Lymphocytes: attackers and targets of the same oncogenic viruses, depending on their immunogenic strengthG Mathé
ZWR|January 10, 1973
[New ways in crown and bridge constructions]G Mathé
Drugs|January 1, 1974
Current status of immunotherapy of human cancers: leukaemias, lymphomas, solid tumoursG Mathé
Pageof 55